Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

910
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
910
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

216
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
216
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

318
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
318
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

344
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
344
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

2.3K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Studies in Continuous Glucose Monitoring.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2025
Same author

Continuous Glucose Monitoring in Practice.

The Journal of family practice·2023
Same author

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?

Clinical diabetes : a publication of the American Diabetes Association·2023
Same author

Update on the Gut Microbiome for the Primary Care Clinician.

The Journal of family practice·2022
Same author

Using Continuous Glucose Monitoring in Clinical Practice.

Clinical diabetes : a publication of the American Diabetes Association·2021
Same author

Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients.

Postgraduate medicine·2020

Related Experiment Videos

Common Questions on Continuous Glucose Monitoring in Primary Care.

Eden M Miller1

  • 1Eden M. Miller, DO, Co-Founder, Diabetes Nation, Diabetes and Obesity Care, Bend, Oregon.

The Journal of Family Practice
|August 12, 2022
PubMed
Summary
This summary is machine-generated.

Continuous glucose monitoring (CGM) offers valuable insights beyond fingerstick self-monitoring of blood glucose (SMBG). Utilizing CGM data, like the ambulatory glucose profile (AGP), helps optimize diabetes treatment plans and improve patient outcomes.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Management

Background:

  • Traditional self-monitoring of blood glucose (SMBG) provides limited data for comprehensive glycemic control.
  • Continuous glucose monitoring (CGM) systems offer real-time and historical glucose readings, enhancing diabetes management.
  • The ambulatory glucose profile (AGP) is a key tool for interpreting CGM data and assessing glycemic control.

Purpose of the Study:

  • To differentiate patient suitability for CGM versus SMBG.
  • To elucidate the data interpretation capabilities of CGM systems.
  • To demonstrate the application of AGP in evaluating time in range (TIR) targets and guiding treatment adjustments for improved patient outcomes.

Main Methods:

  • Comparative analysis of patient candidacy for CGM versus SMBG.
  • Exploration of data outputs from various CGM systems.
  • Application of AGP for TIR assessment based on International Consensus guidelines.
  • Treatment plan modification strategies informed by CGM-derived insights.

Main Results:

  • CGM provides a more detailed glycemic picture than SMBG, aiding in identifying trends and patterns.
  • AGP facilitates objective assessment of TIR, highlighting periods of hyperglycemia and hypoglycemia.
  • Data-driven treatment adjustments based on CGM and AGP lead to improved glycemic control and patient outcomes.

Conclusions:

  • CGM is a powerful tool for optimizing diabetes care, offering deeper insights than SMBG.
  • Effective interpretation of CGM data, particularly through AGP, is crucial for achieving target glycemic control.
  • Personalized treatment modifications guided by CGM data are essential for improving the quality of life for individuals with diabetes.